162 related articles for article (PubMed ID: 31702860)
1. Synthesis and Anticancer Activity of Tertiary Amides of Salinomycin and Their C20-oxo Analogues.
Czerwonka D; Urbaniak A; Sobczak S; Piña-Oviedo S; Chambers TC; Antoszczak M; Huczyński A
ChemMedChem; 2020 Jan; 15(2):236-246. PubMed ID: 31702860
[TBL] [Abstract][Full Text] [Related]
2. Singly and doubly modified analogues of C20-epi-salinomycin: A new group of antiparasitic agents against Trypanosoma brucei.
Czerwonka D; Barcelos Y; Steverding D; Cioch A; Huczyński A; Antoszczak M
Eur J Med Chem; 2021 Jan; 209():112900. PubMed ID: 33071053
[TBL] [Abstract][Full Text] [Related]
3. Biological activity of doubly modified salinomycin analogs - Evaluation in vitro and ex vivo.
Antoszczak M; Urbaniak A; Delgado M; Maj E; Borgström B; Wietrzyk J; Huczyński A; Yuan Y; Chambers TC; Strand D
Eur J Med Chem; 2018 Aug; 156():510-523. PubMed ID: 30025346
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antiproliferative and antibacterial activity of new amides of salinomycin.
Antoszczak M; Maj E; Stefańska J; Wietrzyk J; Janczak J; Brzezinski B; Huczyński A
Bioorg Med Chem Lett; 2014 Apr; 24(7):1724-9. PubMed ID: 24631190
[TBL] [Abstract][Full Text] [Related]
5. Ester derivatives of salinomycin efficiently eliminate breast cancer cells via ER-stress-induced apoptosis.
Kuran D; Flis S; Antoszczak M; Piskorek M; Huczyński A
Eur J Pharmacol; 2021 Feb; 893():173824. PubMed ID: 33347821
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, anticancer and antibacterial activity of salinomycin N-benzyl amides.
Antoszczak M; Maj E; Napiórkowska A; Stefańska J; Augustynowicz-Kopeć E; Wietrzyk J; Janczak J; Brzezinski B; Huczyński A
Molecules; 2014 Nov; 19(12):19435-59. PubMed ID: 25429565
[TBL] [Abstract][Full Text] [Related]
7. Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models.
Urbaniak A; Reed MR; Fil D; Moorjani A; Heflin S; Antoszczak M; Sulik M; Huczyński A; Kupsik M; Eoff RL; MacNicol MC; Chambers TC; MacNicol AM
Biomed Pharmacother; 2021 Sep; 141():111815. PubMed ID: 34130123
[TBL] [Abstract][Full Text] [Related]
8. Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives-An In Vitro Study.
Michalak M; Lach MS; Antoszczak M; Huczyński A; Suchorska WM
Molecules; 2020 Jan; 25(3):. PubMed ID: 31991882
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-tumor activity evaluation of salinomycin C20-
Li B; Wu J; Tang L; Lian X; Li Z; Duan W; Qin T; Zhao X; Hu Y; Zhang C; Li T; Hao J; Zhang W; Zhang J; Wu S
Org Biomol Chem; 2022 Jan; 20(4):870-876. PubMed ID: 35006233
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of salinomycin triazole analogues as anticancer agents.
Huang M; Deng Z; Tian J; Liu T
Eur J Med Chem; 2017 Feb; 127():900-908. PubMed ID: 27876192
[TBL] [Abstract][Full Text] [Related]
11. Semisynthesis of SY-1 for investigation of breast cancer stem cell selectivity of C-ring-modified salinomycin analogues.
Huang X; Borgström B; Månsson L; Persson L; Oredsson S; Hegardt C; Strand D
ACS Chem Biol; 2014 Jul; 9(7):1587-94. PubMed ID: 24841425
[TBL] [Abstract][Full Text] [Related]
12. Salinomycin derivatives exhibit activity against primary acute lymphoblastic leukemia (ALL) cells in vitro.
Urbaniak A; Delgado M; Antoszczak M; Huczyński A; Chambers TC
Biomed Pharmacother; 2018 Mar; 99():384-390. PubMed ID: 29367107
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of conformationally constrained salinomycin derivatives.
Zhang W; Wu J; Li B; Lian X; Xia J; Zhou Q; Wu S
Eur J Med Chem; 2017 Sep; 138():353-356. PubMed ID: 28688275
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative activity of salinomycin and its derivatives.
Huczyński A; Janczak J; Antoszczak M; Wietrzyk J; Maj E; Brzezinski B
Bioorg Med Chem Lett; 2012 Dec; 22(23):7146-50. PubMed ID: 23079523
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the anticancer activity of singly and doubly modified analogues of C20-epi-salinomycin.
Czerwonka D; Mielczarek-Puta M; Antoszczak M; Cioch A; Struga M; Huczyński A
Eur J Pharmacol; 2021 Oct; 908():174347. PubMed ID: 34265289
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Antiproliferative Activity of Silybin Conjugates with Salinomycin and Monensin.
Antoszczak M; Klejborowska G; Kruszyk M; Maj E; Wietrzyk J; Huczyński A
Chem Biol Drug Des; 2015 Dec; 86(6):1378-86. PubMed ID: 26058448
[TBL] [Abstract][Full Text] [Related]
17. Anti-trypanosomal activity of doubly modified salinomycin derivatives.
Antoszczak M; Steverding D; Sulik M; Janczak J; Huczyński A
Eur J Med Chem; 2019 Jul; 173():90-98. PubMed ID: 30986574
[TBL] [Abstract][Full Text] [Related]
18. Activity of singly and doubly modified derivatives of C20-epi-salinomycin against Staphylococcus strains.
Czerwonka D; Podsiad M; Stefańska J; Antoszczak M; Huczyński A
J Antibiot (Tokyo); 2022 Aug; 75(8):445-453. PubMed ID: 35760901
[TBL] [Abstract][Full Text] [Related]
19. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling.
Lu Y; Ma W; Mao J; Yu X; Hou Z; Fan S; Song B; Wang H; Li J; Kang L; Liu P; Liu Q; Li L
Chem Biol Interact; 2015 Feb; 228():100-7. PubMed ID: 25499043
[TBL] [Abstract][Full Text] [Related]
20. The synthesis and evaluation of the antiproliferative activity of deacidified GEX1A analogues.
Imaizumi T; Nakagawa H; Hori R; Watanabe Y; Soga S; Iida K; Onodera H
J Antibiot (Tokyo); 2017 May; 70(5):675-679. PubMed ID: 28096548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
